Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/54492 |
Resumo: | Inova Fiocruz – Fundação Oswaldo Cruz. Coordenação de Aperfeiçoamento de Pessoal da Nível Superior - Brésil (CAPES). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Fundação de Amparo à Projeto de Pesquisa do Estado da Bahia (FAPESB) |
id |
CRUZ_bb84d565a827977737be6832ac482058 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/54492 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Silva, Icaro BonyekSilva, Thiago CerqueiraNunes, SaraMachado, Antônio Fernando AraújoCruz, Márrcio Rivison SilvaPereira, BlendaEstrela, LeilaneSilva, JéssicaIsis, AnandaBarral, AldinaOliveira, Pablo Rafael SilveiraKhouri, RicardoSerezani, C. HenriqueBrodskyn, CláudiaCaldas, Juliana RibeiroBarral Netto, ManoelBoaventura, VivianeTavares, Natalia Machado2022-08-08T17:19:06Z2022-08-08T17:19:06Z2022SILVA, Icaro Bonyek et al. Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms. Frontiers in Endocrinology, v. 13, p. 1-9, 2022.1664-2392https://www.arca.fiocruz.br/handle/icict/5449210.3389/fendo.2022.896378Inova Fiocruz – Fundação Oswaldo Cruz. Coordenação de Aperfeiçoamento de Pessoal da Nível Superior - Brésil (CAPES). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Fundação de Amparo à Projeto de Pesquisa do Estado da Bahia (FAPESB)Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil / Instituto Federal de Educação. Ciência e Tecnologia Baiano. Xique-Xique, BA, Brasil / Faculdade de Santa Cruz da Bahia. Escola de enfermagem. Itaberaba, BA, Brasil,Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Universidade Salvador. Escola de Ciências da Saúde. Salvador, BA, Brasil.Universidade Salvador. Escola de Ciências da Saúde. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil / Instituto Nacional de Ciência e Tecnologia. Instituto de Investigação em Imunologia. São Paulo, SP, Brasil.Universidade Federal do Bahia. Instituto de Ciências Biológicas. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Vanderbilt University Medical Center. Department of Medicine. Division of Infectious Diseases. Nashville, TN, United States.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil / Instituto Nacional de Ciência e Tecnologia. Instituto de Investigação em Imunologia. São Paulo, SP, Brasil.Universidade Salvador. Escola de Ciências da Saúde. Salvador, BA, Brasil. Hospital São Rafael. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil / Instituto Nacional de Ciência e Tecnologia. Instituto de Investigação em Imunologia. São Paulo, SP, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil / Instituto Nacional de Ciência e Tecnologia. Instituto de Investigação em Imunologia. São Paulo, SP, Brasil.Aims: Pre-existing conditions, such as age, hypertension, obesity, and diabetes, constitute known risk factors for severe COVID-19. However, the impact of prediabetes mellitus (PDM) on COVID-19 severity is less clear. This study aimed to evaluate the influence of PDM in the acute and long-term phases of COVID-19. Materials and methods: We compared inflammatory mediators, laboratory and clinical parameters and symptoms in COVID-19 patients with prediabetes (PDM) and without diabetes (NDM) during the acute phase of infection and at three months post-hospitalization. Results: Patients with PDM had longer hospital stays and required intensive care unit admission more frequently than NDM. Upon hospitalization, PDM patients exhibited higher serum levels of interleukin 6 (IL-6), which is related to reduced partial pressure of oxygen (PaO2) in arterial blood, oxygen saturation (SpO2) and increased COVID-19 severity. However, at three months after discharge, those with PDM did not exhibit significant alterations in laboratory parameters or residual symptoms; however, PDM was observed to influence the profile of reported symptoms. Conclusions: PDM seems to be associated with increased risk of severe COVID-19, as well as higher serum levels of IL-6, which may constitute a potential biomarker of severe COVID-19 risk in affected patients. Furthermore, while PDM correlated with more severe acute-phase COVID-19, no long-term worsening of sequelae was observed.engFrontiers MediaPrediabetic StateInflammationCOVID-19Pré-diabéticoInflamaçãoCOVID-19Interleucina-6PrediabeticInflammationCOVID-19Interleukin-6PrediabéticoInflamaciónCOVID-19Interleucina-6État prédiabétiqueInflammationSARS-CoV-2Interleukine-6Estado pré-diabéticoInflamaçãoCOVID-19Interleucina-6Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptomsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/54492/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALSilva, Icaro Bonyek - Prediabetes Induces....pdfSilva, Icaro Bonyek - Prediabetes Induces....pdfapplication/pdf3475618https://www.arca.fiocruz.br/bitstream/icict/54492/2/Silva%2c%20Icaro%20Bonyek%20-%20Prediabetes%20Induces....pdfa53f3d229ba33597c9d8e64f855bcaf7MD52icict/544922023-03-15 14:34:35.367oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:35Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms |
title |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms |
spellingShingle |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms Silva, Icaro Bonyek Prediabetic State Inflammation COVID-19 Pré-diabético Inflamação COVID-19 Interleucina-6 Prediabetic Inflammation COVID-19 Interleukin-6 Prediabético Inflamación COVID-19 Interleucina-6 État prédiabétique Inflammation SARS-CoV-2 Interleukine-6 Estado pré-diabético Inflamação COVID-19 Interleucina-6 |
title_short |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms |
title_full |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms |
title_fullStr |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms |
title_full_unstemmed |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms |
title_sort |
Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms |
author |
Silva, Icaro Bonyek |
author_facet |
Silva, Icaro Bonyek Silva, Thiago Cerqueira Nunes, Sara Machado, Antônio Fernando Araújo Cruz, Márrcio Rivison Silva Pereira, Blenda Estrela, Leilane Silva, Jéssica Isis, Ananda Barral, Aldina Oliveira, Pablo Rafael Silveira Khouri, Ricardo Serezani, C. Henrique Brodskyn, Cláudia Caldas, Juliana Ribeiro Barral Netto, Manoel Boaventura, Viviane Tavares, Natalia Machado |
author_role |
author |
author2 |
Silva, Thiago Cerqueira Nunes, Sara Machado, Antônio Fernando Araújo Cruz, Márrcio Rivison Silva Pereira, Blenda Estrela, Leilane Silva, Jéssica Isis, Ananda Barral, Aldina Oliveira, Pablo Rafael Silveira Khouri, Ricardo Serezani, C. Henrique Brodskyn, Cláudia Caldas, Juliana Ribeiro Barral Netto, Manoel Boaventura, Viviane Tavares, Natalia Machado |
author2_role |
author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Silva, Icaro Bonyek Silva, Thiago Cerqueira Nunes, Sara Machado, Antônio Fernando Araújo Cruz, Márrcio Rivison Silva Pereira, Blenda Estrela, Leilane Silva, Jéssica Isis, Ananda Barral, Aldina Oliveira, Pablo Rafael Silveira Khouri, Ricardo Serezani, C. Henrique Brodskyn, Cláudia Caldas, Juliana Ribeiro Barral Netto, Manoel Boaventura, Viviane Tavares, Natalia Machado |
dc.subject.mesh.pt_BR.fl_str_mv |
Prediabetic State Inflammation COVID-19 |
topic |
Prediabetic State Inflammation COVID-19 Pré-diabético Inflamação COVID-19 Interleucina-6 Prediabetic Inflammation COVID-19 Interleukin-6 Prediabético Inflamación COVID-19 Interleucina-6 État prédiabétique Inflammation SARS-CoV-2 Interleukine-6 Estado pré-diabético Inflamação COVID-19 Interleucina-6 |
dc.subject.other.pt_BR.fl_str_mv |
Pré-diabético Inflamação COVID-19 Interleucina-6 |
dc.subject.en.pt_BR.fl_str_mv |
Prediabetic Inflammation COVID-19 Interleukin-6 |
dc.subject.es.pt_BR.fl_str_mv |
Prediabético Inflamación COVID-19 Interleucina-6 |
dc.subject.fr.pt_BR.fl_str_mv |
État prédiabétique Inflammation SARS-CoV-2 Interleukine-6 |
dc.subject.decs.pt_BR.fl_str_mv |
Estado pré-diabético Inflamação COVID-19 Interleucina-6 |
description |
Inova Fiocruz – Fundação Oswaldo Cruz. Coordenação de Aperfeiçoamento de Pessoal da Nível Superior - Brésil (CAPES). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Fundação de Amparo à Projeto de Pesquisa do Estado da Bahia (FAPESB) |
publishDate |
2022 |
dc.date.accessioned.fl_str_mv |
2022-08-08T17:19:06Z |
dc.date.available.fl_str_mv |
2022-08-08T17:19:06Z |
dc.date.issued.fl_str_mv |
2022 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
SILVA, Icaro Bonyek et al. Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms. Frontiers in Endocrinology, v. 13, p. 1-9, 2022. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/54492 |
dc.identifier.issn.pt_BR.fl_str_mv |
1664-2392 |
dc.identifier.doi.none.fl_str_mv |
10.3389/fendo.2022.896378 |
identifier_str_mv |
SILVA, Icaro Bonyek et al. Prediabetes induces more severe acute COVID-19 associated with IL-6 production without worsening long-term symptoms. Frontiers in Endocrinology, v. 13, p. 1-9, 2022. 1664-2392 10.3389/fendo.2022.896378 |
url |
https://www.arca.fiocruz.br/handle/icict/54492 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Frontiers Media |
publisher.none.fl_str_mv |
Frontiers Media |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/54492/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/54492/2/Silva%2c%20Icaro%20Bonyek%20-%20Prediabetes%20Induces....pdf |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 a53f3d229ba33597c9d8e64f855bcaf7 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008844178063360 |